Skip to main content
. 2014 Nov 12;89(2):1340–1347. doi: 10.1128/JVI.02565-14

TABLE 1.

Characteristics of PML patients and PML patient samples used in this study

Patient no. Gendera Clinical backgroundb JC virus load(s) (no. of copies/ml)
Urine Plasma CSF
1 M RRMS 5,562,426, 179,375,000, 172,000,000, >225,000,000 69,718
2 F Liver transplant 51,006, 26,912 278,000,000
3 F RRMS 10,812, 4,063 96,438
4 M RRMS 5,035 2,238,800
5 F RRMS 558,967, 756,637, 12,728
6 M RRMS 29,584
7 F MS 15,912
8 F Lymphoma 100,046
9 M RRMS 1,627,025
10 F MS 26,633
11 F MS 181,566
12 M MS 656,020
13 F RRMS 2,501,045
14 F CLL 72,734
15 M MS 43,694,938
16 F MS 94,545,825
17 M MS 189,945,812
18 M RRMS 7,744,225
19 F RRMS 2,804,051
a

M, male; F, female.

b

MS, Multiple sclerosis; RRMS, relapsing-remitting multiple sclerosis; CLL, chronic lymphocytic leukemia.